Insmed (INSM) Gross Profit (2018 - 2026)

Insmed's Gross Profit history runs 9 years deep, the most recent figure standing at $258.5 million for Q1 2026.

• In Q1 2026, Gross Profit rose 261.37% year-over-year to $258.5 million; the TTM figure through Mar 2026 stood at $670.5 million (up 130.04% YoY), while the FY2025 annual figure was $483.5 million, up 73.94% from the prior year.
• Gross Profit was $258.5 million for Q1 2026 at Insmed, up from $219.6 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $258.5 million in Q1 2026 to a low of $40.9 million in Q1 2022.
• Historically, Gross Profit has averaged $85.3 million across 5 years, with a median of $65.2 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Gross Profit grew 7.93% in 2022, then surged 261.37% in 2026.
• A 5-year view of Gross Profit shows it stood at $46.2 million in 2022, then surged by 41.14% to $65.2 million in 2023, then rose by 19.99% to $78.3 million in 2024, then soared by 180.52% to $219.6 million in 2025, then rose by 17.72% to $258.5 million in 2026.
• The last three Gross Profit figures came in at $258.5 million (Q1 2026), $219.6 million (Q4 2025), and $113.0 million (Q3 2025), per Business Quant data.